Here are four updates on GI companies from the past week:
Valeant reported net revenues of $2.21 billion in the third quarter of fiscal year 2017.
Exact Sciences is building a second laboratory facility in Madison, Wis., to meet growing demand for the company's Cologuard test. The company also announced it would serve as the title sponsor of the Cologuard Classic, a PGA Tour Champions event in Tucson, Ariz.
Lumendi made its DiLumen Ig Endolumenal Interventional Grasper available in the U.S.
The last patient enrolled in Immuron's IMM-124E phase II study completed their final visit. Results from the trial could be available as soon as the first quarter of 2018.